Literature DB >> 12235350

Special focus session. MR arthrography.

Lynne S Steinbach1, William E Palmer, Mark E Schweitzer.   

Abstract

Direct magnetic resonance (MR) arthrography with injection of saline solution or diluted gadolinium can be useful for evaluating certain pathologic conditions in the joints. It is most helpful for outlining labral-ligamentous abnormalities in the shoulder and distinguishing partial-thickness from full-thickness tears in the rotator cuff, demonstrating labral tears in the hip, showing partial- and full-thickness tears of the collateral ligament of the elbow and delineating bands in the elbow, identifying residual or recurrent tears in the knee following meniscectomy, increasing the certainty of perforations of the ligaments and triangular fibrocartilage in the wrist, correctly identifying ligament tears in the ankle and increasing the sensitivity for ankle impingement syndromes, assessing the stability of osteochondral lesions in the articular surface of joints, and delineating loose bodies in joints. Indirect MR arthrography with intravenous administration of diluted gadolinium may be performed when direct arthrography is inconvenient or not logistically feasible. Although indirect MR arthrography has some disadvantages vis-à-vis direct MR arthrography, it does not require fluoroscopic guidance or joint injection and it is superior to conventional MR imaging in delineating structures when there is minimal joint fluid. In addition, vascularized or inflamed tissue will enhance with this method. Indirect MR arthrography can be used to rule in or diagnose abnormalities and to exclude abnormalities.

Entities:  

Mesh:

Year:  2002        PMID: 12235350     DOI: 10.1148/radiographics.22.5.g02se301223

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  57 in total

Review 1.  Direct magnetic resonance arthrography.

Authors:  Dmitry Elentuck; William E Palmer
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

2.  Shaken or swirled? Mixing gadolinium for arthrography.

Authors:  Andrew D Scott; David Leswick
Journal:  Skeletal Radiol       Date:  2012-03-21       Impact factor: 2.199

3.  Ultrasound guidance to perform intra-articular injection of gadolinium-based contrast material for magnetic resonance arthrography as an alternative to fluoroscopy: the time is now.

Authors:  Carmelo Messina; Giuseppe Banfi; Alberto Aliprandi; Giovanni Mauri; Francesco Secchi; Francesco Sardanelli; Luca Maria Sconfienza
Journal:  Eur Radiol       Date:  2015-08-08       Impact factor: 5.315

Review 4.  [Magnetic resonance tomography and arthrography of the hip joint].

Authors:  G Schneider; A Massmann; P Fries; M Kusma; M Dienst
Journal:  Orthopade       Date:  2006-01       Impact factor: 1.087

Review 5.  The optimal use of contrast agents at high field MRI.

Authors:  Siegfried Trattnig; Kathia Pinker; Ahmed Ba-Ssalamah; Iris-Melanie Nöbauer-Huhmann
Journal:  Eur Radiol       Date:  2006-03-01       Impact factor: 5.315

6.  The role of popliteal lymph nodes in differentiating rheumatoid arthritis from osteoarthritis by using CE 3D FSPGR MR imaging: relationship of the inflamed synovial volume.

Authors:  Yong-Min Huh; Sungjun Kim; Jin-Suck Suh; Ho- Taek Song; Kijun Song; Kyoo-Ho Shin
Journal:  Korean J Radiol       Date:  2005 Apr-Jun       Impact factor: 3.500

Review 7.  Technical errors in MR arthrography.

Authors:  Juerg Hodler
Journal:  Skeletal Radiol       Date:  2007-05-26       Impact factor: 2.199

Review 8.  [Femoroacetabular impingement. Clinical and radiological diagnostics].

Authors:  M Kusma; F Bachelier; G Schneider; M Dienst
Journal:  Orthopade       Date:  2009-05       Impact factor: 1.087

Review 9.  MR arthrography made simple: indications and techniques.

Authors:  John D MacKenzie
Journal:  Pediatr Radiol       Date:  2008-05

10.  Inappropriate requests for magnetic resonance scans of the shoulder.

Authors:  Richard Freeman; Sanjay Khanna; David Ricketts
Journal:  Int Orthop       Date:  2013-06-22       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.